Bioconjugate Chemistry, ISSN 1043-1802, 12/2014, Volume 25, Issue 12, pp. 2144 - 2156
Highly potent biotoxins like Pseudomonas exotoxin A (ETA) are attractive payloads for tumor targeting. However, despite replacement of the natural cell-binding...
RECOMBINANT IMMUNOTOXIN | ANIMAL TOXICITY | DRUG-DELIVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | ANKYRIN REPEAT PROTEINS | B-CELL EPITOPES | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | POLYETHYLENE-GLYCOL | PSEUDOMONAS EXOTOXIN | PENETRATING PEPTIDES | Cell Adhesion Molecules - chemistry | Cysteine Endopeptidases - chemistry | Recombinant Fusion Proteins - pharmacology | Area Under Curve | Humans | Half-Life | Polyethylene Glycols - chemistry | Prodrugs - chemistry | Antigens, Neoplasm - chemistry | Viral Proteins - metabolism | Epithelial Cell Adhesion Molecule | Cysteine Endopeptidases - metabolism | Drug Design | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Binding Sites | ADP Ribose Transferases - chemistry | Exotoxins - chemistry | Click Chemistry | Viral Proteins - chemistry | Mice, Inbred C57BL | Ankyrin Repeat | Virulence Factors - chemistry | Recombinant Fusion Proteins - chemistry | Antineoplastic Agents - chemistry | Bacterial Toxins - chemistry | Animals | Cell Line, Tumor | Recombinant Fusion Proteins - genetics | Prodrugs - pharmacology | Index Medicus
RECOMBINANT IMMUNOTOXIN | ANIMAL TOXICITY | DRUG-DELIVERY | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | ANKYRIN REPEAT PROTEINS | B-CELL EPITOPES | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | POLYETHYLENE-GLYCOL | PSEUDOMONAS EXOTOXIN | PENETRATING PEPTIDES | Cell Adhesion Molecules - chemistry | Cysteine Endopeptidases - chemistry | Recombinant Fusion Proteins - pharmacology | Area Under Curve | Humans | Half-Life | Polyethylene Glycols - chemistry | Prodrugs - chemistry | Antigens, Neoplasm - chemistry | Viral Proteins - metabolism | Epithelial Cell Adhesion Molecule | Cysteine Endopeptidases - metabolism | Drug Design | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Binding Sites | ADP Ribose Transferases - chemistry | Exotoxins - chemistry | Click Chemistry | Viral Proteins - chemistry | Mice, Inbred C57BL | Ankyrin Repeat | Virulence Factors - chemistry | Recombinant Fusion Proteins - chemistry | Antineoplastic Agents - chemistry | Bacterial Toxins - chemistry | Animals | Cell Line, Tumor | Recombinant Fusion Proteins - genetics | Prodrugs - pharmacology | Index Medicus
Journal Article
Advanced Materials, ISSN 0935-9648, 02/2013, Volume 25, Issue 8, pp. 1203 - 1208
Multifunctional cationic conjugated polyelectrolyte (CP)‐coated bacteria are fabricated for drug loading, delivery and release with multimodal anticancer...
toxin loading and release | bacteria | imaging | conjugated polymers | anticancer | POLYELECTROLYTES | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | MICROSPHERES | MATERIALS SCIENCE, MULTIDISCIPLINARY | ESCHERICHIA-COLI | CONTROLLED-RELEASE | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | DELIVERY | NANOPARTICLES | IMMUNOTOXIN | ASSEMBLIES | EXPRESSION | Polymyxin B - chemistry | ADP Ribose Transferases - toxicity | Cell Survival - drug effects | Bacteria - chemistry | Cations - chemistry | Reactive Oxygen Species - metabolism | Exotoxins - chemistry | Humans | Bacterial Toxins - toxicity | Virulence Factors - chemistry | Antineoplastic Agents - chemistry | Electrolytes - chemistry | Escherichia coli - chemistry | Bacterial Toxins - chemistry | Antineoplastic Agents - toxicity | Polymyxin B - toxicity | Light | Cell Line, Tumor | Exotoxins - toxicity | Polymers - chemistry | ADP Ribose Transferases - chemistry | Virulence Factors - toxicity | Bacteria | Care and treatment | Polymer industry | Polymers | Cancer
toxin loading and release | bacteria | imaging | conjugated polymers | anticancer | POLYELECTROLYTES | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | MICROSPHERES | MATERIALS SCIENCE, MULTIDISCIPLINARY | ESCHERICHIA-COLI | CONTROLLED-RELEASE | CHEMISTRY, PHYSICAL | NANOSCIENCE & NANOTECHNOLOGY | CHEMISTRY, MULTIDISCIPLINARY | CANCER-THERAPY | DELIVERY | NANOPARTICLES | IMMUNOTOXIN | ASSEMBLIES | EXPRESSION | Polymyxin B - chemistry | ADP Ribose Transferases - toxicity | Cell Survival - drug effects | Bacteria - chemistry | Cations - chemistry | Reactive Oxygen Species - metabolism | Exotoxins - chemistry | Humans | Bacterial Toxins - toxicity | Virulence Factors - chemistry | Antineoplastic Agents - chemistry | Electrolytes - chemistry | Escherichia coli - chemistry | Bacterial Toxins - chemistry | Antineoplastic Agents - toxicity | Polymyxin B - toxicity | Light | Cell Line, Tumor | Exotoxins - toxicity | Polymers - chemistry | ADP Ribose Transferases - chemistry | Virulence Factors - toxicity | Bacteria | Care and treatment | Polymer industry | Polymers | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, p. e0131177
Antibody drug conjugates (ADCs) have recently been proven to be highly potent anti-tumor drugs, typically exceeding the efficacy of conventional monoclonal...
RECOMBINANT IMMUNOTOXIN | IMMUNOGENICITY | MULTIDISCIPLINARY SCIENCES | PURIFICATION | SURFACE-PROTEINS | STAPHYLOCOCCUS-AUREUS | ANTITUMOR-ACTIVITY | MONOCLONAL-ANTIBODIES | FRAGMENTATION | CANCER-THERAPY | PROTEIN LIGATION | Cysteine Endopeptidases - chemistry | Staphylococcus aureus - enzymology | Aminoacyltransferases - immunology | Receptor, ErbB-2 - genetics | Humans | Bacterial Proteins - chemistry | Ovarian Neoplasms - pathology | Ki-1 Antigen - immunology | Maytansine - pharmacology | Immunoconjugates - immunology | Immunoconjugates - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Protein Engineering | Maytansine - chemistry | Female | Antineoplastic Agents - pharmacology | Bacterial Proteins - immunology | Receptor, ErbB-2 - antagonists & inhibitors | Receptor, ErbB-2 - immunology | Oligopeptides - chemistry | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Aminoacyltransferases - chemistry | Antineoplastic Agents - immunology | Maytansine - analogs & derivatives | Antibodies, Monoclonal - pharmacology | Oligopeptides - immunology | Antineoplastic Agents - chemistry | Immunoconjugates - chemistry | Staphylococcus aureus - chemistry | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Ki-1 Antigen - antagonists & inhibitors | Mice | Antibodies, Monoclonal, Humanized - immunology | Cysteine Endopeptidases - immunology | Maytansine - immunology | Trastuzumab | Antibodies, Monoclonal, Humanized - chemistry | Ki-1 Antigen - genetics | Ovarian Neoplasms - immunology | Monoclonal antibodies | Enzymes | Cysteine | Peptides | Biopharmaceutics | Drugs | Conjugates | Addition polymerization | Ovarian carcinoma | Clinical trials | Pentaglycine | Cancer therapies | Molecular weight | Ovarian cancer | Proteins | Tubulin | CD30 antigen | Xenografts | Medical research | Immunoglobulins | Polypeptides | Cloning | Polymerization | Breast cancer | ErbB-2 protein | Substrates | Chemotherapy | Lysine | Heavy chains | Toxins | Conjugation | Sortase | Tumors
RECOMBINANT IMMUNOTOXIN | IMMUNOGENICITY | MULTIDISCIPLINARY SCIENCES | PURIFICATION | SURFACE-PROTEINS | STAPHYLOCOCCUS-AUREUS | ANTITUMOR-ACTIVITY | MONOCLONAL-ANTIBODIES | FRAGMENTATION | CANCER-THERAPY | PROTEIN LIGATION | Cysteine Endopeptidases - chemistry | Staphylococcus aureus - enzymology | Aminoacyltransferases - immunology | Receptor, ErbB-2 - genetics | Humans | Bacterial Proteins - chemistry | Ovarian Neoplasms - pathology | Ki-1 Antigen - immunology | Maytansine - pharmacology | Immunoconjugates - immunology | Immunoconjugates - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Protein Engineering | Maytansine - chemistry | Female | Antineoplastic Agents - pharmacology | Bacterial Proteins - immunology | Receptor, ErbB-2 - antagonists & inhibitors | Receptor, ErbB-2 - immunology | Oligopeptides - chemistry | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Aminoacyltransferases - chemistry | Antineoplastic Agents - immunology | Maytansine - analogs & derivatives | Antibodies, Monoclonal - pharmacology | Oligopeptides - immunology | Antineoplastic Agents - chemistry | Immunoconjugates - chemistry | Staphylococcus aureus - chemistry | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Ki-1 Antigen - antagonists & inhibitors | Mice | Antibodies, Monoclonal, Humanized - immunology | Cysteine Endopeptidases - immunology | Maytansine - immunology | Trastuzumab | Antibodies, Monoclonal, Humanized - chemistry | Ki-1 Antigen - genetics | Ovarian Neoplasms - immunology | Monoclonal antibodies | Enzymes | Cysteine | Peptides | Biopharmaceutics | Drugs | Conjugates | Addition polymerization | Ovarian carcinoma | Clinical trials | Pentaglycine | Cancer therapies | Molecular weight | Ovarian cancer | Proteins | Tubulin | CD30 antigen | Xenografts | Medical research | Immunoglobulins | Polypeptides | Cloning | Polymerization | Breast cancer | ErbB-2 protein | Substrates | Chemotherapy | Lysine | Heavy chains | Toxins | Conjugation | Sortase | Tumors
Journal Article
FEMS Microbiology Reviews, ISSN 0168-6445, 03/2007, Volume 31, Issue 2, pp. 212 - 237
Abstract RNase T1 is the best known representative of a large family of ribonucleolytic proteins secreted by fungi, mostly Aspergillus and Penicillium species....
Aspf1 | immunotoxin | filamentous fungi | sarcin | RNase | Immunotoxin | Sarcin | Filamentous fungi | RIBOSOME-INACTIVATING PROTEIN | PROTEIN ALPHA-SARCIN | PSEUDOMONAS EXOTOXIN-A | MICROBIOLOGY | RIBONUCLEOLYTIC TOXIN RESTRICTOCIN | T-CELL IMMUNOTOXIN | YEAST PICHIA-PASTORIS | AMINO-ACID-SEQUENCE | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | RICIN A-CHAIN | CONSTITUENT-PEPTIDE CHAINS | Fungal Proteins - chemistry | Amino Acid Sequence | Endoribonucleases - chemistry | Endoribonucleases - metabolism | Mycotoxins - chemistry | Ribonucleases - chemistry | Aspergillus - chemistry | Ribosomes - chemistry | Molecular Sequence Data | Fungi - chemistry | Ribonucleases - metabolism | Allergens - metabolism | Penicillium - chemistry | Allergens - chemistry | Immunotoxins - metabolism | Immunotoxins - chemistry | Mycotoxins - metabolism | Fungal Proteins - metabolism | RNA - metabolism
Aspf1 | immunotoxin | filamentous fungi | sarcin | RNase | Immunotoxin | Sarcin | Filamentous fungi | RIBOSOME-INACTIVATING PROTEIN | PROTEIN ALPHA-SARCIN | PSEUDOMONAS EXOTOXIN-A | MICROBIOLOGY | RIBONUCLEOLYTIC TOXIN RESTRICTOCIN | T-CELL IMMUNOTOXIN | YEAST PICHIA-PASTORIS | AMINO-ACID-SEQUENCE | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | RICIN A-CHAIN | CONSTITUENT-PEPTIDE CHAINS | Fungal Proteins - chemistry | Amino Acid Sequence | Endoribonucleases - chemistry | Endoribonucleases - metabolism | Mycotoxins - chemistry | Ribonucleases - chemistry | Aspergillus - chemistry | Ribosomes - chemistry | Molecular Sequence Data | Fungi - chemistry | Ribonucleases - metabolism | Allergens - metabolism | Penicillium - chemistry | Allergens - chemistry | Immunotoxins - metabolism | Immunotoxins - chemistry | Mycotoxins - metabolism | Fungal Proteins - metabolism | RNA - metabolism
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 06/2015, Volume 26, Issue 6, pp. 1120 - 1128
Recombinant immunotoxins (RITs) are fusion proteins that join antibodies to protein toxins for targeted cell killing. RITs aimed with Pseudomonas exotoxin A...
TARGET | LOW IMMUNOGENICITY | TOXIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | INFUSION | CYTOTOXIC ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | RESISTANT | PHASE-I TRIAL | LEUKEMIA | ANTI-MESOTHELIN IMMUNOTOXIN | CAT-8015 | Recombinant Fusion Proteins - pharmacology | Humans | Immunotoxins - pharmacology | Recombinant Fusion Proteins - metabolism | Exotoxins - metabolism | Antineoplastic Agents - metabolism | Immunotoxins - metabolism | Immunotoxins - chemistry | Antineoplastic Agents - pharmacology | ADP Ribose Transferases - chemistry | ADP Ribose Transferases - metabolism | Furin - metabolism | Amino Acid Sequence | Cell Survival - drug effects | Exotoxins - chemistry | Leukemia - drug therapy | Models, Molecular | Exotoxins - pharmacology | Virulence Factors - chemistry | Recombinant Fusion Proteins - chemistry | Antineoplastic Agents - chemistry | Bacterial Toxins - chemistry | Bacterial Toxins - metabolism | Bacterial Toxins - pharmacology | ADP Ribose Transferases - pharmacology | Cell Line, Tumor | Virulence Factors - metabolism | Virulence Factors - pharmacology | Index Medicus
TARGET | LOW IMMUNOGENICITY | TOXIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | INFUSION | CYTOTOXIC ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | RESISTANT | PHASE-I TRIAL | LEUKEMIA | ANTI-MESOTHELIN IMMUNOTOXIN | CAT-8015 | Recombinant Fusion Proteins - pharmacology | Humans | Immunotoxins - pharmacology | Recombinant Fusion Proteins - metabolism | Exotoxins - metabolism | Antineoplastic Agents - metabolism | Immunotoxins - metabolism | Immunotoxins - chemistry | Antineoplastic Agents - pharmacology | ADP Ribose Transferases - chemistry | ADP Ribose Transferases - metabolism | Furin - metabolism | Amino Acid Sequence | Cell Survival - drug effects | Exotoxins - chemistry | Leukemia - drug therapy | Models, Molecular | Exotoxins - pharmacology | Virulence Factors - chemistry | Recombinant Fusion Proteins - chemistry | Antineoplastic Agents - chemistry | Bacterial Toxins - chemistry | Bacterial Toxins - metabolism | Bacterial Toxins - pharmacology | ADP Ribose Transferases - pharmacology | Cell Line, Tumor | Virulence Factors - metabolism | Virulence Factors - pharmacology | Index Medicus
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 10/2014, Volume 25, Issue 10, pp. 1871 - 1880
The stability of the connection between the antibody and the toxin can have a profound impact on ADC safety and efficacy. There has been increasing evidence in...
ANTIBODY-DRUG CONJUGATE | LINKER STABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | MICE | CHEMISTRY, MULTIDISCIPLINARY | IMMUNOCONJUGATE | Immunotoxins - blood | Drug Stability | Humans | Sulfides - chemistry | Succinimides - chemistry | Neoplasms - drug therapy | Hydrolysis | Animals | Immunotoxins - therapeutic use | Cell Line, Tumor | Immunotoxins - chemistry | Mice | Protein Stability | Neoplasms - pathology
ANTIBODY-DRUG CONJUGATE | LINKER STABILITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | MICE | CHEMISTRY, MULTIDISCIPLINARY | IMMUNOCONJUGATE | Immunotoxins - blood | Drug Stability | Humans | Sulfides - chemistry | Succinimides - chemistry | Neoplasms - drug therapy | Hydrolysis | Animals | Immunotoxins - therapeutic use | Cell Line, Tumor | Immunotoxins - chemistry | Mice | Protein Stability | Neoplasms - pathology
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 04/2011, Volume 22, Issue 4, pp. 717 - 727
In this report, we describe the synthesis of a panel of disulfide-linked huC242 (anti-CanAg) antibody maytansinoid conjugates (AMCs), which have varying levels...
XENOGRAFT MODELS | DRUG CONJUGATE | SOLID TUMORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | MULTIPLE-MYELOMA CELLS | CANTUZUMAB MERTANSINE | CANCER | CHEMISTRY, MULTIDISCIPLINARY | IMMUNOCONJUGATE | RICIN-A-CHAIN | PHASE-I | IMMUNOTOXINS | Antibodies - chemistry | Colonic Neoplasms - drug therapy | Humans | Molecular Conformation | Disulfides - blood | Antineoplastic Agents - chemistry | Mice, Inbred Strains | Mice, SCID | Maytansine - pharmacology | Carbon - chemistry | Colonic Neoplasms - metabolism | Antibodies - pharmacology | Xenograft Model Antitumor Assays | Animals | Disulfides - chemistry | Antineoplastic Agents - blood | Maytansine - chemistry | Antibodies - blood | Disulfides - pharmacology | Antineoplastic Agents - pharmacology | Mice | Maytansine - blood
XENOGRAFT MODELS | DRUG CONJUGATE | SOLID TUMORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | MULTIPLE-MYELOMA CELLS | CANTUZUMAB MERTANSINE | CANCER | CHEMISTRY, MULTIDISCIPLINARY | IMMUNOCONJUGATE | RICIN-A-CHAIN | PHASE-I | IMMUNOTOXINS | Antibodies - chemistry | Colonic Neoplasms - drug therapy | Humans | Molecular Conformation | Disulfides - blood | Antineoplastic Agents - chemistry | Mice, Inbred Strains | Mice, SCID | Maytansine - pharmacology | Carbon - chemistry | Colonic Neoplasms - metabolism | Antibodies - pharmacology | Xenograft Model Antitumor Assays | Animals | Disulfides - chemistry | Antineoplastic Agents - blood | Maytansine - chemistry | Antibodies - blood | Disulfides - pharmacology | Antineoplastic Agents - pharmacology | Mice | Maytansine - blood
Journal Article
The FEBS Journal, ISSN 1742-464X, 12/2011, Volume 278, Issue 23, pp. 4683 - 4700
Pseudomonas exotoxin A (PE) is a highly toxic protein secreted by the opportunistic pathogen Pseudomonas aeruginosa. The modular structure and corresponding...
cancer therapy | intracellular trafficking | recombinant immunotoxins | moxetumomab pasudotox | Pseudomonas exotoxin A | antibody conjugates | ELONGATION FACTOR-II | DISULFIDE-STABILIZED FV | BIOCHEMISTRY & MOLECULAR BIOLOGY | B-CELL EPITOPES | DIPHTHERIA-TOXIN | GROWTH-FACTOR-ALPHA | IN-VIVO | ENDOPLASMIC-RETICULUM | CONSERVED FRAMEWORK REGIONS | ANTI-MESOTHELIN IMMUNOTOXIN | ENDOGENOUS ADP-RIBOSYLATION | ADP Ribose Transferases - immunology | Immunotoxins - immunology | Exotoxins - chemistry | Recombinant Fusion Proteins - pharmacology | Bacterial Toxins - immunology | Exotoxins - immunology | Humans | Exotoxins - pharmacology | Virulence Factors - chemistry | Virulence Factors - immunology | Recombinant Fusion Proteins - chemistry | Immunotoxins - pharmacology | Recombinant Fusion Proteins - metabolism | Bacterial Toxins - chemistry | Neoplasms - therapy | Pseudomonas aeruginosa - pathogenicity | Bacterial Toxins - pharmacology | Neoplasms - immunology | Pseudomonas aeruginosa - metabolism | ADP Ribose Transferases - pharmacology | Immunotoxins - chemistry | Protein Conformation | ADP Ribose Transferases - chemistry | Virulence Factors - pharmacology | Care and treatment | Drug therapy | Antibody-toxin conjugates | Cancer | Index Medicus
cancer therapy | intracellular trafficking | recombinant immunotoxins | moxetumomab pasudotox | Pseudomonas exotoxin A | antibody conjugates | ELONGATION FACTOR-II | DISULFIDE-STABILIZED FV | BIOCHEMISTRY & MOLECULAR BIOLOGY | B-CELL EPITOPES | DIPHTHERIA-TOXIN | GROWTH-FACTOR-ALPHA | IN-VIVO | ENDOPLASMIC-RETICULUM | CONSERVED FRAMEWORK REGIONS | ANTI-MESOTHELIN IMMUNOTOXIN | ENDOGENOUS ADP-RIBOSYLATION | ADP Ribose Transferases - immunology | Immunotoxins - immunology | Exotoxins - chemistry | Recombinant Fusion Proteins - pharmacology | Bacterial Toxins - immunology | Exotoxins - immunology | Humans | Exotoxins - pharmacology | Virulence Factors - chemistry | Virulence Factors - immunology | Recombinant Fusion Proteins - chemistry | Immunotoxins - pharmacology | Recombinant Fusion Proteins - metabolism | Bacterial Toxins - chemistry | Neoplasms - therapy | Pseudomonas aeruginosa - pathogenicity | Bacterial Toxins - pharmacology | Neoplasms - immunology | Pseudomonas aeruginosa - metabolism | ADP Ribose Transferases - pharmacology | Immunotoxins - chemistry | Protein Conformation | ADP Ribose Transferases - chemistry | Virulence Factors - pharmacology | Care and treatment | Drug therapy | Antibody-toxin conjugates | Cancer | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, pp. e110824 - e110824
The use of pore-forming toxins in the construction of immunotoxins against tumour cells is an alternative for cancer therapy. In this protein family one of the...
MODEL MEMBRANES | PROTEIN | MECHANISM | CYTOLYSIN EQUINATOXIN-II | SEA-ANEMONE | MULTIDISCIPLINARY SCIENCES | FORMING TOXIN | CONSTRUCTION | ANEMONE STICHODACTYLA-HELIANTHUS | LIPID-MEMBRANES | INSIGHTS | Hemolysis | Protein Structure, Tertiary | Protein Structure, Secondary | Humans | Organic Chemicals - chemistry | Sea Anemones - genetics | Recombinant Proteins - chemistry | Ions | Electric Conductivity | Cysteine - chemistry | Permeability | Phosphatidylcholines - chemistry | Sea Anemones - chemistry | Erythrocytes - drug effects | Cryoelectron Microscopy | Lipids - chemistry | Liposomes - chemistry | Animals | Adsorption | Immunotoxins - chemistry | Lipid Bilayers - chemistry | Mutation | Index Medicus
MODEL MEMBRANES | PROTEIN | MECHANISM | CYTOLYSIN EQUINATOXIN-II | SEA-ANEMONE | MULTIDISCIPLINARY SCIENCES | FORMING TOXIN | CONSTRUCTION | ANEMONE STICHODACTYLA-HELIANTHUS | LIPID-MEMBRANES | INSIGHTS | Hemolysis | Protein Structure, Tertiary | Protein Structure, Secondary | Humans | Organic Chemicals - chemistry | Sea Anemones - genetics | Recombinant Proteins - chemistry | Ions | Electric Conductivity | Cysteine - chemistry | Permeability | Phosphatidylcholines - chemistry | Sea Anemones - chemistry | Erythrocytes - drug effects | Cryoelectron Microscopy | Lipids - chemistry | Liposomes - chemistry | Animals | Adsorption | Immunotoxins - chemistry | Lipid Bilayers - chemistry | Mutation | Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2008, Volume 128, Issue 3, pp. 209 - 216
The clinical use of immunotoxins is severely limited by nonspecific toxicity. To overcome this limitation, PE38KDEL was used as a model protein toxin to...
Nanoparticles | rhuMAbHER2 | Immunotoxins | PLGA | Targeted delivery | VASCULAR LEAK SYNDROME | L-ASPARAGINASE | CELLS | MEMBRANE ANTIGEN | targeted delivery | MONOCLONAL-ANTIBODY | CHEMISTRY, MULTIDISCIPLINARY | CELLULAR UPTAKE | IN-VITRO | nanoparticles | IMMUNOLIPOSOMES | PROSTATE-CANCER | PHARMACOLOGY & PHARMACY | immunotoxins | ANTICANCER DRUGS | ADP Ribose Transferases - toxicity | Antibody Specificity | Breast Neoplasms - immunology | Humans | Immunotoxins - pharmacology | Glycolates - chemistry | Endocytosis | Time Factors | Surface Properties | Receptor, ErbB-2 - immunology | Immunoglobulin Fab Fragments | Antibodies, Monoclonal - chemistry | ADP Ribose Transferases - metabolism | Virulence Factors - toxicity | Cell Survival - drug effects | Exotoxins - chemistry | Antibodies, Monoclonal - pharmacology | Polyglycolic Acid | Recombinant Proteins - chemistry | Breast Neoplasms - drug therapy | Bacterial Toxins - chemistry | Particle Size | Mice, Nude | Cell Line, Tumor | Exotoxins - toxicity | Virulence Factors - metabolism | Mice | Mice, Inbred BALB C | Antibodies, Monoclonal - metabolism | Bacterial Toxins - toxicity | Exotoxins - metabolism | Drug Carriers | Antineoplastic Agents - metabolism | Dose-Response Relationship, Drug | Immunotoxins - metabolism | Inhibitory Concentration 50 | Female | Immunotoxins - chemistry | Antineoplastic Agents - pharmacology | ADP Ribose Transferases - chemistry | Lactic Acid | Virulence Factors - chemistry | Recombinant Proteins - pharmacology | Antineoplastic Agents - chemistry | Xenograft Model Antitumor Assays | Bacterial Toxins - metabolism | Animals | Breast Neoplasms - pathology | Medical colleges | Care and treatment | Transmission electron microscopes | Drugstores | Antineoplastic agents | Antimitotic agents | Analysis | Monoclonal antibodies | Chemical properties | Antibody-toxin conjugates | Health aspects | Cancer | Index Medicus
Nanoparticles | rhuMAbHER2 | Immunotoxins | PLGA | Targeted delivery | VASCULAR LEAK SYNDROME | L-ASPARAGINASE | CELLS | MEMBRANE ANTIGEN | targeted delivery | MONOCLONAL-ANTIBODY | CHEMISTRY, MULTIDISCIPLINARY | CELLULAR UPTAKE | IN-VITRO | nanoparticles | IMMUNOLIPOSOMES | PROSTATE-CANCER | PHARMACOLOGY & PHARMACY | immunotoxins | ANTICANCER DRUGS | ADP Ribose Transferases - toxicity | Antibody Specificity | Breast Neoplasms - immunology | Humans | Immunotoxins - pharmacology | Glycolates - chemistry | Endocytosis | Time Factors | Surface Properties | Receptor, ErbB-2 - immunology | Immunoglobulin Fab Fragments | Antibodies, Monoclonal - chemistry | ADP Ribose Transferases - metabolism | Virulence Factors - toxicity | Cell Survival - drug effects | Exotoxins - chemistry | Antibodies, Monoclonal - pharmacology | Polyglycolic Acid | Recombinant Proteins - chemistry | Breast Neoplasms - drug therapy | Bacterial Toxins - chemistry | Particle Size | Mice, Nude | Cell Line, Tumor | Exotoxins - toxicity | Virulence Factors - metabolism | Mice | Mice, Inbred BALB C | Antibodies, Monoclonal - metabolism | Bacterial Toxins - toxicity | Exotoxins - metabolism | Drug Carriers | Antineoplastic Agents - metabolism | Dose-Response Relationship, Drug | Immunotoxins - metabolism | Inhibitory Concentration 50 | Female | Immunotoxins - chemistry | Antineoplastic Agents - pharmacology | ADP Ribose Transferases - chemistry | Lactic Acid | Virulence Factors - chemistry | Recombinant Proteins - pharmacology | Antineoplastic Agents - chemistry | Xenograft Model Antitumor Assays | Bacterial Toxins - metabolism | Animals | Breast Neoplasms - pathology | Medical colleges | Care and treatment | Transmission electron microscopes | Drugstores | Antineoplastic agents | Antimitotic agents | Analysis | Monoclonal antibodies | Chemical properties | Antibody-toxin conjugates | Health aspects | Cancer | Index Medicus
Journal Article
11.
Full Text
Hindered Disulfide Bonds to Regulate Release Rate of Model Drug from Mesoporous Silica
ACS Applied Materials & Interfaces, ISSN 1944-8244, 05/2013, Volume 5, Issue 9, pp. 3908 - 3915
With the advancement of drug delivery systems based on mesoporous silica nanoparticles (MSNs), a simple and efficient method regulating the drug release...
controlled release | mesoporous silica | nanoparticles | drug delivery | redox | SYSTEM | PORE-SIZE | ZEBRAFISH | STRATEGY | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | FUNCTIONALIZATION | RESPONSIVE CONTROLLED-RELEASE | IN-VIVO | IMMUNOTOXINS | INTRACELLULAR CONTROLLED-RELEASE | Fluorescent Dyes - chemistry | Fluorescent Dyes - pharmacokinetics | Models, Chemical | Nanoparticles - chemistry | Oxidation-Reduction | Silicon Dioxide - chemistry | Delayed-Action Preparations - chemistry | Drug Carriers - toxicity | Zebrafish | Rhodamines - pharmacokinetics | Nanoparticles - toxicity | Drug Carriers - chemistry | Animals | beta-Cyclodextrins - chemistry | Disulfides - chemistry | Embryo, Nonmammalian | Rhodamines - chemistry | Toxicity Tests
controlled release | mesoporous silica | nanoparticles | drug delivery | redox | SYSTEM | PORE-SIZE | ZEBRAFISH | STRATEGY | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | FUNCTIONALIZATION | RESPONSIVE CONTROLLED-RELEASE | IN-VIVO | IMMUNOTOXINS | INTRACELLULAR CONTROLLED-RELEASE | Fluorescent Dyes - chemistry | Fluorescent Dyes - pharmacokinetics | Models, Chemical | Nanoparticles - chemistry | Oxidation-Reduction | Silicon Dioxide - chemistry | Delayed-Action Preparations - chemistry | Drug Carriers - toxicity | Zebrafish | Rhodamines - pharmacokinetics | Nanoparticles - toxicity | Drug Carriers - chemistry | Animals | beta-Cyclodextrins - chemistry | Disulfides - chemistry | Embryo, Nonmammalian | Rhodamines - chemistry | Toxicity Tests
Journal Article
Accounts of Chemical Research, ISSN 0001-4842, 01/2008, Volume 41, Issue 1, pp. 108 - 119
A long-standing problem in cancer chemotherapy is the lack of tumor-specific treatments. Traditional chemotherapy relies on the premise that rapidly...
Taxoids - chemistry | Fluorescent Dyes - chemistry | Fluorescent Dyes - pharmacokinetics | Drug Carriers - therapeutic use | Biotin - pharmacokinetics | Humans | Antibodies, Monoclonal - therapeutic use | Drug Carriers - chemistry | Neoplasms - drug therapy | Biotin - chemistry | Taxoids - therapeutic use | Animals | Immunotoxins - therapeutic use | Nanotubes, Carbon - chemistry | Drug Design | Immunotoxins - chemistry | Immunotoxins - pharmacokinetics | Drug Carriers - pharmacokinetics | Antibodies, Monoclonal - chemistry | Antimitotic agents | Drugs | Drug delivery systems | Chemotherapy | Usage | Product development | Research | Antineoplastic agents | Vehicles | Cancer
Taxoids - chemistry | Fluorescent Dyes - chemistry | Fluorescent Dyes - pharmacokinetics | Drug Carriers - therapeutic use | Biotin - pharmacokinetics | Humans | Antibodies, Monoclonal - therapeutic use | Drug Carriers - chemistry | Neoplasms - drug therapy | Biotin - chemistry | Taxoids - therapeutic use | Animals | Immunotoxins - therapeutic use | Nanotubes, Carbon - chemistry | Drug Design | Immunotoxins - chemistry | Immunotoxins - pharmacokinetics | Drug Carriers - pharmacokinetics | Antibodies, Monoclonal - chemistry | Antimitotic agents | Drugs | Drug delivery systems | Chemotherapy | Usage | Product development | Research | Antineoplastic agents | Vehicles | Cancer
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 02/2014, Volume 13, Issue 2, pp. 375 - 385
Fusion toxins used for cancer-related therapy have demonstrated short circulation half-lives, which impairs tumor localization and, hence, efficacy. Here, we...
HALF-LIFE | CELL-ADHESION MOLECULE | ANKYRIN REPEAT PROTEIN | ONCOLOGY | DARPINS | ANTIBODY | CHEMICAL-MODIFICATION | POLYETHYLENE-GLYCOL | PSEUDOMONAS EXOTOXIN | IMMUNOTOXINS | ANTIGEN | Cell Adhesion Molecules - chemistry | Neoplasms - metabolism | Surface Plasmon Resonance | Cell Adhesion Molecules - genetics | Virulence Factors - genetics | Recombinant Fusion Proteins - pharmacology | Humans | Polyethylene Glycols - chemistry | Antigens, Neoplasm - chemistry | Epithelial Cell Adhesion Molecule | MCF-7 Cells | Bacterial Toxins - genetics | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | ADP Ribose Transferases - chemistry | Antigens, Neoplasm - genetics | Cell Survival - drug effects | Exotoxins - chemistry | Click Chemistry | Electrophoresis, Polyacrylamide Gel | Virulence Factors - chemistry | Recombinant Fusion Proteins - chemistry | Antineoplastic Agents - chemistry | Bacterial Toxins - chemistry | Neoplasms - drug therapy | HT29 Cells | Xenograft Model Antitumor Assays | ADP Ribose Transferases - genetics | Animals | Tumor Burden - drug effects | Mice, Nude | Recombinant Fusion Proteins - pharmacokinetics | Exotoxins - genetics | Cell Line, Tumor | Neoplasms - pathology
HALF-LIFE | CELL-ADHESION MOLECULE | ANKYRIN REPEAT PROTEIN | ONCOLOGY | DARPINS | ANTIBODY | CHEMICAL-MODIFICATION | POLYETHYLENE-GLYCOL | PSEUDOMONAS EXOTOXIN | IMMUNOTOXINS | ANTIGEN | Cell Adhesion Molecules - chemistry | Neoplasms - metabolism | Surface Plasmon Resonance | Cell Adhesion Molecules - genetics | Virulence Factors - genetics | Recombinant Fusion Proteins - pharmacology | Humans | Polyethylene Glycols - chemistry | Antigens, Neoplasm - chemistry | Epithelial Cell Adhesion Molecule | MCF-7 Cells | Bacterial Toxins - genetics | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | ADP Ribose Transferases - chemistry | Antigens, Neoplasm - genetics | Cell Survival - drug effects | Exotoxins - chemistry | Click Chemistry | Electrophoresis, Polyacrylamide Gel | Virulence Factors - chemistry | Recombinant Fusion Proteins - chemistry | Antineoplastic Agents - chemistry | Bacterial Toxins - chemistry | Neoplasms - drug therapy | HT29 Cells | Xenograft Model Antitumor Assays | ADP Ribose Transferases - genetics | Animals | Tumor Burden - drug effects | Mice, Nude | Recombinant Fusion Proteins - pharmacokinetics | Exotoxins - genetics | Cell Line, Tumor | Neoplasms - pathology
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2014, Volume 111, Issue 23, pp. 8577 - 8582
Immune responses can make protein therapeutics ineffective or even dangerous. We describe a general computational protein design method for reducing...
T lymphocytes | Immune response | Immunodominant epitopes | Exotoxins | Medical treatment | Alleles | T lymphocyte epitopes | Epitopes | Genetic mutation | Epics | Biotherapeutics | Immunotoxin | Deimmunization | Machine learning | Rosetta | biotherapeutics | MULTIDISCIPLINARY SCIENCES | ANTIBODY | deimmunization | ALGORITHMS | machine learning | IDENTIFICATION | GREEN FLUORESCENT PROTEIN | REDUCED IMMUNOGENICITY | THERAPEUTIC PROTEINS | immunotoxin | OPTIMIZATION | PHASE-I | Virulence Factors - genetics | Protein Engineering - methods | Humans | Molecular Sequence Data | Epitopes, T-Lymphocyte - genetics | Green Fluorescent Proteins - genetics | Virulence Factors - immunology | HLA Antigens - genetics | Support Vector Machine | Flow Cytometry | Bacterial Toxins - genetics | Immunotoxins - chemistry | Epitopes, T-Lymphocyte - immunology | Green Fluorescent Proteins - chemistry | ADP Ribose Transferases - chemistry | Protein Structure, Tertiary | ADP Ribose Transferases - immunology | Immunization | Immunotoxins - immunology | Exotoxins - chemistry | Bacterial Toxins - immunology | Exotoxins - immunology | Mice, Inbred C57BL | HLA Antigens - immunology | Models, Molecular | Spectrometry, Fluorescence | Virulence Factors - chemistry | Bacterial Toxins - chemistry | Proteins - immunology | Proteins - genetics | Sequence Homology, Amino Acid | ADP Ribose Transferases - genetics | Immunotoxins - genetics | Animals | Green Fluorescent Proteins - immunology | Exotoxins - genetics | Cell Line, Tumor | Mice | Computer-Aided Design | Proteins - chemistry | Microbiological research | Protein research | Peptides | Research | Pseudomonas | T cells | Health aspects | Index Medicus | Biological Sciences | Physical Sciences
T lymphocytes | Immune response | Immunodominant epitopes | Exotoxins | Medical treatment | Alleles | T lymphocyte epitopes | Epitopes | Genetic mutation | Epics | Biotherapeutics | Immunotoxin | Deimmunization | Machine learning | Rosetta | biotherapeutics | MULTIDISCIPLINARY SCIENCES | ANTIBODY | deimmunization | ALGORITHMS | machine learning | IDENTIFICATION | GREEN FLUORESCENT PROTEIN | REDUCED IMMUNOGENICITY | THERAPEUTIC PROTEINS | immunotoxin | OPTIMIZATION | PHASE-I | Virulence Factors - genetics | Protein Engineering - methods | Humans | Molecular Sequence Data | Epitopes, T-Lymphocyte - genetics | Green Fluorescent Proteins - genetics | Virulence Factors - immunology | HLA Antigens - genetics | Support Vector Machine | Flow Cytometry | Bacterial Toxins - genetics | Immunotoxins - chemistry | Epitopes, T-Lymphocyte - immunology | Green Fluorescent Proteins - chemistry | ADP Ribose Transferases - chemistry | Protein Structure, Tertiary | ADP Ribose Transferases - immunology | Immunization | Immunotoxins - immunology | Exotoxins - chemistry | Bacterial Toxins - immunology | Exotoxins - immunology | Mice, Inbred C57BL | HLA Antigens - immunology | Models, Molecular | Spectrometry, Fluorescence | Virulence Factors - chemistry | Bacterial Toxins - chemistry | Proteins - immunology | Proteins - genetics | Sequence Homology, Amino Acid | ADP Ribose Transferases - genetics | Immunotoxins - genetics | Animals | Green Fluorescent Proteins - immunology | Exotoxins - genetics | Cell Line, Tumor | Mice | Computer-Aided Design | Proteins - chemistry | Microbiological research | Protein research | Peptides | Research | Pseudomonas | T cells | Health aspects | Index Medicus | Biological Sciences | Physical Sciences
Journal Article